Savara (SVRA) Non-Current Deferred Tax Liability (2011 - 2018)

Savara (SVRA) reported Non-Current Deferred Tax Liability of $2.5 million for Q3 2018, down 77.5% year-over-year from $11.3 million in Q3 2017, and down 0.78% on a QoQ basis from $2.6 million in Q2 2018.

Savara (SVRA) has 8 years of Non-Current Deferred Tax Liability data on file, last reported at $2.5 million in Q3 2018.

  • Quarterly Non-Current Deferred Tax Liability fell 77.5% year-over-year to $2.5 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $2.5 million (down 77.5% YoY) and the FY2017 annual result came in at $7.2 million, up 211.54% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $2.5 million in Q3 2018 per SVRA's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $11.3 million in Q3 2017 and bottomed at $995000.0 in Q1 2017.
  • The 5-year median for Non-Current Deferred Tax Liability is $3.4 million (2014), against an average of $4.1 million.
  • The widest annual swing landed in 2017, when Non-Current Deferred Tax Liability surged 230.88%; it then plunged 77.5% in 2018.
  • Tracing SVRA's Non-Current Deferred Tax Liability over 5 years: stood at $3.4 million in 2014, then changed by 0.0% to $3.4 million in 2015, then sank by 32.29% to $2.3 million in 2016, then soared by 211.54% to $7.2 million in 2017, then tumbled by 64.71% to $2.5 million in 2018.
  • Per Business Quant, the three latest SVRA Non-Current Deferred Tax Liability figures stand at $2.5 million (Q3 2018), $2.6 million (Q2 2018), and $2.7 million (Q1 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Savara 1.30 Bn 1.30 Bn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2018 2.53 Mn
Sep 30, 2018 2.53 Mn
Jun 30, 2018 2.55 Mn
Jun 30, 2018 2.55 Mn
Mar 31, 2018 2.69 Mn
Mar 31, 2018 2.69 Mn
Dec 31, 2017 7.18 Mn
Dec 31, 2017 7.18 Mn
Sep 30, 2017 11.26 Mn
Sep 30, 2017 11.26 Mn
Jun 30, 2017 11.18 Mn
Jun 30, 2017 11.18 Mn
Mar 31, 2017 995,000.00
Mar 31, 2017 995,000.00
Dec 31, 2016 2.31 Mn
Dec 31, 2016 2.31 Mn
Sep 30, 2016 3.40 Mn
Sep 30, 2016 3.40 Mn
Jun 30, 2016 3.40 Mn
Jun 30, 2016 3.40 Mn
Mar 31, 2016 3.40 Mn
Mar 31, 2016 3.40 Mn
Dec 31, 2015 3.40 Mn
Dec 31, 2015 3.40 Mn
Sep 30, 2015 3.40 Mn
Sep 30, 2015 3.40 Mn
Jun 30, 2015 3.40 Mn
Jun 30, 2015 3.40 Mn
Mar 31, 2015 3.40 Mn
Mar 31, 2015 3.40 Mn
Dec 31, 2014 3.40 Mn
Dec 31, 2014 3.40 Mn
Sep 30, 2014 3.40 Mn
Sep 30, 2014 3.40 Mn
Jun 30, 2014 3.40 Mn
Jun 30, 2014 3.40 Mn
Mar 31, 2014 3.40 Mn
Mar 31, 2014 3.40 Mn
Dec 31, 2013 2.61 Mn
Dec 31, 2013 2.61 Mn
Sep 30, 2013 2.61 Mn
Sep 30, 2013 2.61 Mn
Jun 30, 2013 2.61 Mn
Jun 30, 2013 2.61 Mn
Mar 31, 2013 2.61 Mn
Mar 31, 2013 2.61 Mn
Dec 31, 2012 2.61 Mn
Dec 31, 2012 2.61 Mn
Sep 30, 2012 2.61 Mn
Sep 30, 2012 2.61 Mn
Jun 30, 2012 2.61 Mn
Jun 30, 2012 2.61 Mn
Mar 31, 2012 2.61 Mn
Mar 31, 2012 2.61 Mn
Dec 31, 2011 2.61 Mn
Dec 31, 2011 2.61 Mn